Close Menu

NEW YORK — Centogene said on Wednesday that it has signed an agreement giving access to its rare disease data repository to Pfizer for use in the discovery of novel drug targets.

Centogene said the repository includes a range of rare disease patient data including clinical information, health records, and genetic, transcriptomic, proteomic, and metabolomic data. It also contains longitudinal data such as biomarkers or patient recorded outcomes, as well as diagnostic workflow data.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.

Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.

Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.

In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.